Ultrasound-targeted microbubble destruction (UTMD) in combination with granulocyte colony-stimulating factor (G-CSF) improves cardiac function in myocardial infarction rats

被引:0
|
作者
Xue, Jing [1 ,2 ]
Yuan, Jian-Jun [1 ]
Deng, Tao [3 ]
Zhang, Zhou-Long [2 ]
Chen, Sheng-Jiang [2 ]
机构
[1] Zhengzhou Univ, Peoples Hosp, Dept Ultrasound, 7 Wei Wu Rd, Zhengzhou 450003, Peoples R China
[2] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Ultrasound, Luoyang 471003, Peoples R China
[3] Henan Univ Sci & Technol, Affiliated Hosp 3, Dept Plast Surg, Luoyang 471003, Peoples R China
关键词
Ultrasound-targeted microbubble destruction; granulocyte colony-stimulating factor; myocardial infarction; cardiac function; vascular endothelial growth factor; VENTRICULAR DIASTOLIC FUNCTION; STEM-CELL TRANSPLANTATION; VASCULOGENESIS; ANGIOGENESIS; IRISIN; MICE; HEMATOPOIESIS; DOPPLER; HUMANS; REPAIR;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives: The aim of this study is to determine the effect of ultrasound-targeted microbubble destruction in combination with granulocyte colony-stimulating factor (G-CSF) on revascularization and cardiac function in myocardial infarction rats. Materials and Methods: A total of 40 Wistar rats were successfully constructed as myocardial infarction (MI) model and randomly divided into four groups. Group A, B, C, and D were treated for two weeks with ultrasound, microbubble and G-CSF (UTMD+G-CSF), or ultrasound and microbubble (UTMD), or G-CSF, or surgery control (SC), respectively. Then, the expression of myocardial CD34 was analyzed by immunohistochemistry (IHC) method; the level of microvessel density (MVD) in myocardium was counted; the expression of myocardial vascular endothelial growth factor (VEGF) and Irisin were detected by enzyme linked immunosorbent assay (ELISA), Western blot and quantitative real-time PCR (qPCR) assay. Additionally, cardiac function tests were conducted by echocardiography in all MI rats. Results: Serum Irisin levels of all the MI rats were significantly lower than the control, which indicated the successful construction of MI model. Significant differences (P < 0.05) between group A and other groups were obtained in this study. Massive expression of CD34, with the most obvious neovascularization (MVD: 231.20 +/- 24.48), was observed in group A by IHC; meanwhile, the highest expression of myocardial VEGF (3.23 +/- 0.21 ng/g) and Irisin (607.4 ng/mL) were measured by ELISA, which was confirmed by Western blot and qPCR assays, as the brightest band in group A was observed. Comparison of the left heart function revealed that increased ejection fraction (EF%) (56.78 +/- 7.23) and fractional shortening (FS) (28.23 +/- 4.98%) with decreased TDI-Tei (0.43 +/- 0.11) were appeared in group A when compared with other groups. Conclusions: Combined treatment of ultrasound-targeted microbubble destruction and G-CSF administration can promote revascularization and improve cardiac function in myocardial infarction rats.
引用
收藏
页码:1748 / 1755
页数:8
相关论文
共 50 条
  • [31] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AND GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) - RECEPTOR BIOLOGY, SIGNAL TRANSDUCTION, AND NEUTROPHIL ACTIVATION
    RAPOPORT, AP
    ABBOUD, CN
    DIPERSIO, JF
    BLOOD REVIEWS, 1992, 6 (01) : 43 - 57
  • [32] Granulocyte colony-stimulating factor improves cardiac function after myocardial infarction via acceleration of reparative collagen synthesis
    Sugano, Y
    Anzai, T
    Maekawa, Y
    Kohno, T
    Mahara, K
    Yoshikawa, T
    CIRCULATION, 2003, 108 (17) : 140 - 140
  • [33] Combined treatment with erythropoietin and granulocyte colony-stimulating factor enhances neovascularization and improves cardiac function after myocardial infarction
    Xue Jingyi
    Du Guoqing
    Shi Jing
    Li Yue
    Yasutake, Masahiro
    Liu Lei
    Li Jianqiang
    Kong Yihui
    Wang Shuxian
    Yun Fengxiang
    Li Weimin
    CHINESE MEDICAL JOURNAL, 2014, 127 (09) : 1677 - 1683
  • [34] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AND GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) SECRETION BY ADHERENT MONOCYTES MEASURED BY QUANTITATIVE IMMUNOASSAYS
    SALLERFORS, B
    OLOFSSON, T
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1992, 49 (04) : 199 - 207
  • [35] Combined treatment with erythropoietin and granulocyte colony-stimulating factor enhances neovascularization and improves cardiac function after myocardial infarction
    Xue Jingyi
    Du Guoqing
    Shi Jing
    Li Yue
    Masahiro Yasutake
    Liu Lei
    Li Jianqiang
    Kong Yihui
    Wang Shuxian
    Yun Fengxiang
    Li Weimin
    中华医学杂志(英文版), 2014, (09) : 1677 - 1683
  • [36] Roles of granulocyte colony-stimulating factor (G-CSF) in myelopoiesis: An in vivo study in G-CSF deficient mice.
    Nakorn, TN
    Lagasse, E
    Weissman, IL
    BLOOD, 2000, 96 (11) : 455A - 455A
  • [37] The origin and concentrations of granulocyte colony-stimulating factor (G-CSF) in amniotic fluid (AF)
    Calhoun, DA
    Lunoe, M
    Gersting, JA
    Staba, SL
    Christensen, RD
    PEDIATRIC RESEARCH, 2000, 47 (04) : 65A - 65A
  • [38] Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia
    S O’Brien
    H Kantarjian
    M Beran
    C Koller
    M Talpaz
    S Lerner
    MJ Keating
    Leukemia, 1997, 11 : 1631 - 1635
  • [39] GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) - BIOCHEMISTRY, BIOLOGY AND PATHO-PHYSIOLOGY
    WELTE, K
    KLINISCHE PADIATRIE, 1988, 200 (03): : 157 - 164
  • [40] Recombinant granulocyte colony-stimulating factor (G-CSF) in infectious diseases: Still a debate
    Wiedermann, FJ
    Mittermayr, M
    Hoffmann, G
    Schobersberger, W
    WIENER KLINISCHE WOCHENSCHRIFT, 2001, 113 (3-4) : 90 - 96